IXICO Plc Financials
| PHYOF Stock | USD 0.07 0.00 0.00% |
IXICO |
IXICO Plc Stock Summary
IXICO Plc competes with Biostem Technologies, Starpharma Holdings, Zivo Bioscience, Imugene, and Relief Therapeutics. IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom. IXICO PLC operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 93 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Griffin Court, London, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | ixico.com |
| Phone | 44 20 3763 7499 |
| Currency | USD - US Dollar |
IXICO Plc Key Financial Ratios
There are many critical financial ratios that IXICO Plc's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that IXICO plc reports annually and quarterly.| Return On Equity | 0.0861 | |||
| Return On Asset | 0.0393 | |||
| Number Of Employees | 90 | |||
| Beta | 0.7 | |||
| Z Score | 40.8 |
IXICO Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IXICO Plc's current stock value. Our valuation model uses many indicators to compare IXICO Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IXICO Plc competition to find correlations between indicators driving IXICO Plc's intrinsic value. More Info.IXICO plc is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for IXICO plc is roughly 2.19 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IXICO Plc's earnings, one of the primary drivers of an investment's value.Complementary Tools for IXICO Pink Sheet analysis
When running IXICO Plc's price analysis, check to measure IXICO Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IXICO Plc is operating at the current time. Most of IXICO Plc's value examination focuses on studying past and present price action to predict the probability of IXICO Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IXICO Plc's price. Additionally, you may evaluate how the addition of IXICO Plc to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |